There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC – Research Report) and Cabaletta Bio (CABA – Research Report) with bullish sentiments.
Alcon (ALC)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Alcon yesterday and set a price target of $89.00. The company’s shares closed last Wednesday at $84.08.
According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of
Alcon has an analyst consensus of Strong Buy, with a price target consensus of $91.99.
See Insiders’ Hot Stocks on TipRanks >>
Cabaletta Bio (CABA)
In a report released yesterday, Samantha Semenkow from Citi maintained a Buy rating on Cabaletta Bio, with a price target of $30.00. The company’s shares closed last Wednesday at $16.44.
According to TipRanks.com, Semenkow is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cabaletta Bio with a $32.67 average price target, implying a 99.9% upside from current levels. In a report issued on March 21, TD Cowen also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALC:
